(NYSE: AVNT) Avient's forecast annual revenue growth rate of 4.28% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.8%.
Avient's revenue in 2026 is $3,260,200,000.On average, 12 Wall Street analysts forecast AVNT's revenue for 2026 to be $313,173,320,304, with the lowest AVNT revenue forecast at $298,879,862,736, and the highest AVNT revenue forecast at $326,000,782,224. On average, 12 Wall Street analysts forecast AVNT's revenue for 2027 to be $323,801,788,752, with the lowest AVNT revenue forecast at $306,942,838,800, and the highest AVNT revenue forecast at $341,302,111,800.
In 2028, AVNT is forecast to generate $338,095,246,320 in revenue, with the lowest revenue forecast at $318,487,554,528 and the highest revenue forecast at $357,428,063,928.